The Allstate Co. (NYSE:ALL) Position Reduced by Lecap Asset Management Ltd.

Lecap Asset Management Ltd. reduced its position in The Allstate Co. (NYSE:ALL) by 25.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 14,545 shares of the insurance provider’s stock after selling 5,009 shares during the period. Lecap Asset Management Ltd.’s holdings in Allstate were worth $2,758,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Northwest Investment Counselors LLC purchased a new position in Allstate during the 1st quarter worth approximately $26,000. Versant Capital Management Inc raised its position in Allstate by 70.9% during the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock valued at $30,000 after buying an additional 78 shares during the period. Family Firm Inc. purchased a new stake in Allstate in the 2nd quarter worth about $38,000. MCF Advisors LLC boosted its position in Allstate by 33.9% during the 2nd quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after acquiring an additional 84 shares during the period. Finally, First Command Advisory Services Inc. purchased a new position in Allstate during the 2nd quarter valued at about $58,000. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Price Performance

NYSE ALL opened at $192.78 on Wednesday. The Allstate Co. has a 1 year low of $121.70 and a 1 year high of $198.79. The company has a fifty day simple moving average of $187.50 and a 200 day simple moving average of $174.10. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.49. The company has a market cap of $50.88 billion, a P/E ratio of 42.56, a P/E/G ratio of 1.74 and a beta of 0.48.

Allstate (NYSE:ALL) last released its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.33 by $1.28. The company had revenue of $15.71 billion during the quarter, compared to analysts’ expectations of $14.04 billion. Allstate had a net margin of 5.03% and a return on equity of 24.05%. The business’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period in the prior year, the company earned ($4.42) earnings per share. On average, sell-side analysts predict that The Allstate Co. will post 15.19 EPS for the current year.

Insider Buying and Selling at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Thomas J. Wilson sold 90,000 shares of the company’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the completion of the transaction, the chief executive officer now owns 88,552 shares of the company’s stock, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider John E. Dugenske sold 36,367 shares of Allstate stock in a transaction dated Friday, September 20th. The stock was sold at an average price of $191.38, for a total value of $6,959,916.46. Following the sale, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 192,530 shares of company stock valued at $34,967,665 in the last 90 days. 1.80% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ALL shares. Raymond James increased their price target on shares of Allstate from $205.00 to $220.00 and gave the stock a “strong-buy” rating in a research report on Friday, October 4th. Barclays initiated coverage on shares of Allstate in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $175.00 target price for the company. Roth Mkm restated a “buy” rating and set a $200.00 price target on shares of Allstate in a report on Wednesday, August 14th. StockNews.com lowered Allstate from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 21st. Finally, TD Cowen boosted their target price on Allstate from $193.00 to $224.00 and gave the company a “buy” rating in a research note on Tuesday, September 3rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $206.44.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.